IMCD Unveils New Life Sciences Centre in Shanghai to Drive Innovation and Collaboration
IMCD has officially opened its new Life Sciences Centre in Shanghai, reinforcing its commitment to supporting the beauty & personal care, pharmaceutical, and food & nutrition sectors in China. The state-of-the-art facility integrates newly built and upgraded laboratories across these three key industries, creating a collaborative hub designed to enhance cross-sector synergy and elevate the level of technical support offered to customers and partners.
Strategically located within East China University of Science and Technology (ECUST), the centre is set to foster close collaboration with the institution in talent development and innovation initiatives.
Part of IMCD’s global network of over 80 technical centres and laboratories, the new Shanghai Life Sciences Centre combines local expertise with international resources to tackle formulation challenges and accelerate new product development.
Key Highlights of the New Life Sciences Centre:
-
Food & Nutrition Laboratory:
Focused on applications in dairy, bakery, and savoury segments, this lab offers customized product development, including ready-to-eat samples and formulation kits. It also provides technical training, collaborative R&D, industry seminars, and on-site support tailored to the Chinese manufacturing environment. -
Pharmaceutical Laboratory:
Serving the North Asia region, this lab offers reverse engineering, troubleshooting, formulation development, and comparative analysis across various dosage forms—solid, liquid, and semi-solid. It also delivers technical training and specialized services such as rheology testing and chemical analysis. -
Beauty & Personal Care Laboratory:
Supporting formulation development in China and efficacy testing across the Asia-Pacific region, this lab covers skincare, sun care, hair care, toiletries, and color cosmetics. It is equipped with efficacy testing instruments, a collaborative beauty studio, and an in-house hair salon for product testing and demonstrations.
Nicky Huang, Managing Director of IMCD China, commented:“The launch of our new Life Sciences Centre marks an exciting milestone for IMCD in China. It demonstrates our long-term investment in building local capabilities and strengthens our ability to support customers with scientific and market-driven expertise. By combining cutting-edge technical infrastructure with a customer-centric approach, we are creating meaningful opportunities for innovation and growth.”
Looking for chemical products? Let suppliers reach out to you!
2026-06-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
IMCD Opens Beauty and Personal Care Lab in California
-
IMCD Acquires Dong Yang FT, Entering the Korean Beauty Sector
-
IMCD to Acquire 100% of Italian Coatings Distributor Tillmanns
-
IMCD to Acquire Tillmanns
-
IMCD Acquires Chilean Specialty Chemicals Distributor
-
Evonik Expands Polybutadiene Production Capacity in China
-
IMCD to Expand Lubrizol’s Medical Solutions in North America
-
Röhm Obtains ISCC+ Certification for MMA and PMMA in Shanghai
-
Roquette Beauté Opens Cosmetics Co-Innovation Center in Shanghai
-
Specialty Chemicals Giant Synthomer Launches Innovation Center in Shanghai to Meet Chinese Market Needs
Recommend Reading
-
Unilever Acquires Dr. Squatch to Expand Its Men’s Personal Care Business
-
Skala and Lola From Rio Merge to Create a New Brazilian Cosmetics Giant
-
Beiersdorf Launches Eucerin Skincare Brand in Japan
-
Beiersdorf Delivers 2025 Growth Despite Ongoing Market Pressure
-
Procter & Gamble Exits Pakistan Amid Economic Pressures, Ending Three Decades of Operations
-
Port inventory rises, November ethylene glycol price center shifts downward
-
Wacker Invests 300 Million Euros in New Semiconductor-Grade Polysilicon Production Line in Germany
-
November Benzene Market Overview (November 1-28, 2025) in China
-
November dichloromethane weak operation in China
-
On March 18, the Chinese epichlorohydrin market continued to decline